Showing results (91-100 of 186) with videos related to
Sort By:
Pageof 19
Drug Safety|February 20, 2014
A framework for assessing the economic value of pharmacovigilance in low- and middle-income countriesJoseph B Babigumira, Andy Stergachis, Hye Lyn Choi, et al.Health Policy (Amsterdam, Netherlands)|March 16, 2010
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturersJosh J Carlson, Sean D Sullivan, Louis P Garrison, et al.Journal of Medical Economics|January 24, 2020
Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia AKeziah Cook, Shaun P Forbes, Kelly Adamski, et al.Pharmacoeconomics|May 8, 2022
Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung CancerWoojung Lee, William B Wong, Stacey Kowal, et al.The Journal of Infectious Diseases|June 14, 2011
Global eradication of measles: an epidemiologic and economic evaluationAnn Levin, Colleen Burgess, Louis P Garrison, et al.Contemporary Clinical Trials|September 18, 2012
The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)William B Wong, Scott D Ramsey, William E Barlow, et al.Journal of Medical Economics|October 13, 2012
Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysisVictor Barzey, Michael B Atkins, Louis P Garrison, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2024
Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019Louis P Garrison, Boshen Jiao, Zizi Elsisi, et al.Cancer|June 19, 2013
Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 statusLouis P Garrison, Deepa Lalla, Melissa Brammer, et al.Best Practice & Research. Clinical Gastroenterology|November 5, 2013
Modelling the long-term outcomes of bariatric surgery: A review of cost-effectiveness studiesBruce C M Wang, Wesley FurnbackPageof 19